Processa (NASDAQ: PCSA) CAO Wendy Guy buys 1,583 shares in open market

Rhea-AI Filing Summary

Processa Pharmaceuticals Chief Administrative Officer Wendy Guy purchased 1,583 shares of common stock in an open-market transaction at $2.97 per share. After this purchase, she holds 4,693 shares directly and 333 shares indirectly through CorLyst, LLC.

Insider Trade Summary

Net Buyer: 1,583 shares ($4,702)

Net Buy 2 txns

Insider Guy Wendy

Role Chief Administrative Officer

Bought 1,583 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,583	$2.97	$5K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 4,693 shares (Direct); Common Stock — 333 shares (Indirect, By CorLyst, LLC)

Footnotes (1)

Key Figures

Shares purchased: 1,583 shares Purchase price: $2.97 per share Direct holdings after transaction: 4,693 shares +2 more

5 metrics

Shares purchased 1,583 shares Open-market purchase of common stock

Purchase price $2.97 per share Price paid for newly acquired shares

Direct holdings after transaction 4,693 shares Common stock directly owned by Wendy Guy

Indirect holdings after transaction 333 shares Common stock held indirectly via CorLyst, LLC

Net buy shares 1,583 shares Net change in buy/sell activity in this filing

Key Terms

Form 4, open-market purchase, Common Stock, indirect ownership, +1 more

5 terms

Form 4 regulatory

"reported in the Form 4 insider filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

open-market purchase financial

"an open-market purchase of 1,583 Processa Pharmaceuticals shares"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

Common Stock financial

"purchase of 1,583 Processa Pharmaceuticals shares of common stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

indirect ownership financial

"she has an indirect holding of 333 Processa Pharmaceuticals shares"

transaction code “P” regulatory

"The transaction used code “P,” indicating an open-market or private purchase"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Guy Wendy

(Last) (First) (Middle)

C/O PROCESSA PHARMACEUTICALS, INC.

601 21ST STREET SUITE 300

(Street)

VERO BEACH FLORIDA 32960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/15/2026		P		1,583	A	$2.97	4,693	D
Common Stock								333	I	By CorLyst, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did PCSA executive Wendy Guy report?

Wendy Guy reported an open-market purchase of 1,583 Processa Pharmaceuticals shares. She paid $2.97 per share for common stock, indicating a net increase in her direct ownership position as disclosed in the Form 4 insider filing.

What is Wendy Guy’s total direct shareholding in PCSA after this trade?

After the purchase, Wendy Guy directly owns 4,693 Processa Pharmaceuticals shares. This figure reflects her updated direct common stock holdings following the 1,583-share open-market acquisition reported in the Form 4 transaction summary.

Does Wendy Guy have any indirect ownership in Processa Pharmaceuticals (PCSA)?

Yes, she has an indirect holding of 333 Processa Pharmaceuticals shares. These shares are held through CorLyst, LLC, as indicated by the indirect ownership entry with the nature of ownership described as “By CorLyst, LLC” in the filing.

What was the purchase price for the PCSA shares acquired by Wendy Guy?

The shares were purchased at $2.97 per share in an open-market transaction. This price applies to the 1,583 common stock shares acquired, as specified by the transaction_price_per_share field in the Form 4 data.

What type of transaction code was used for Wendy Guy’s PCSA share purchase?

The transaction used code “P,” indicating an open-market or private purchase. The filing describes this as a purchase of common stock in the open market, with the transaction classified as a non-derivative buy transaction.